Levocetirizine in allergic rhinitis and rhinoconjunctivitis treatment(review)
- 作者: Lopatin A1, Latysheva E1, Lopatin A2, Latisheva E2
-
隶属关系:
- Первый Московский государственный медицинский университет им. И.М. Сеченова
- First Moscow State Medical University named after Setchenov, ENT Devision
- 期: 卷 8, 编号 6 (2011)
- 页面: 47-52
- 栏目: Articles
- URL: https://journals.rcsi.science/raj/article/view/121221
- DOI: https://doi.org/10.36691/RJA807
- ID: 121221
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
shown to be able to control all symptoms of allergic rhinitis including nasal obstruction, it has anti-inflammatory
and immunomodulatory activity. Levocetirizine has been proven to be safe even in long-term administration
and has less adverse reactions in comparison with other antihistamine drugs. So, levocetirizine is efficacious
and safe medication for treatment patients with mild-to-moderate seasonal and perennial allergic rhinitis and
rhinoconjunctivitis.
作者简介
A Lopatin
Первый Московский государственный медицинский университет им. И.М. Сеченова
Email: lopatin@lor.ru
Первый Московский государственный медицинский университет им. И.М. Сеченова
E Latysheva
Первый Московский государственный медицинский университет им. И.М. СеченоваПервый Московский государственный медицинский университет им. И.М. Сеченова
A Lopatin
First Moscow State Medical University named after Setchenov, ENT DevisionFirst Moscow State Medical University named after Setchenov, ENT Devision
E Latisheva
First Moscow State Medical University named after Setchenov, ENT DevisionFirst Moscow State Medical University named after Setchenov, ENT Devision
参考
- Sibbald В., Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991, v. 46, p. 895-901.
- Katelaris C.H., Lee B W., Potter P. С., Maspero J.F., Cingi C., Lopatin A. et al. Prevalence and diversity of allergic rhinitis in regions ofthe world beyond Europe and North America. Clin. Exp. Allergy. 2011 (в печати).
- Лопатин А.С. Ринит. М., «Литтерра». 2010.
- ARIA. Allergic rhinitis and its impact on asthma. WHO initiative, 2001.
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт». 1998, 252 с.
- Ciprandi G., Cirillo I., Vizzaccaro A., Tosca M.A. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study Clin. Exp. Allergy. 2004, v. 34, p. 958-964.
- Ciprandi G., Cirillo I., Vizzaccaro A., Civardi E. et al. Dezloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennialallergic rhinitis: A pilot study. International Immunopharmacology 2005, v. 5, p. 1800-1808.
- Mahmound F., Arifhodzic N., Haines D., Novotney L. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis. J. Pharmacol. Sci. 2008, v. 108, p. 149-156.
- Day J.H., Briscoe M.R., Rafeiro E., Ratz J.D. Comparative clinical efficacy, onset and duration of action levocetirizine and dezloratadine for symptoms of seasonal allergic rhinitis in subject evaluated in the Environmental Exposure Unit (EEU). Int. J. Clin. Pract. 2004, v. 58, 2, p. 109-118.
- Jorissen M., Bertrand B., Stiels B., Vandenbulcke K. Levocetirizine as treatment for symptoms of seasonal allergic rhinitis. B-ENT 2006, v. 2, p. 55-62.
- Canonica G.W., Fumagalli F., Guerra L., Baiardini I. et al. Levocetirizine in persistent allergic rhinitis: continuos or on-demand use? A pilot study. Current medical research and opinion. 2008, v. 24, 10, p. 2829-2839.
- Lombardo G., Quattrocchi P., Lombardo G.R., Galati P. et al. Concomitant levocetirizine and montelukast in the treatment of seasonal allergic rhinitis: influence on clinical symptoms. J. Allergy Clin. Immunol. 2006, v. 16, p. 63-68.
- Patel P., Patel D. Efficacy comparison of levocetirizine vs montelucast in ragweed sensitized patients. Ann. Allergy Asthma Immunol. 2008, v. 101, p. 287-294.
